Embecta Corp.
EMBCNASDAQHealthcare● Active
$3.34
$-0.05(-1.33%)
Market Cap$197857803
P/E Ratio—
52W High$15.55
52W Low$2.77
Embecta Corp. (EMBC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
EMBC · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$0.27
Est. $0.42 · -35.7%
Revenue
$0.22B
Est. $0.24B · -5.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
EMBC reports quarterly as a NASDAQ-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.26 | — | — | — | $0.25B | — |
| ▼ Q2 FY2026 | May 5, 2026 | $0.42 | $0.27 | -35.7% | $0.22B | $0.24B | -5.9% |
| ▲ Q1 FY2026 | Feb 5, 2026 | $0.67 | $0.71 | +6.0% | $0.26B | $0.26B | +1.2% |
| ▼ Q4 FY2025 | Nov 25, 2025 | $0.70 | $0.50 | -28.6% | $0.26B | $0.26B | +2.3% |
| ▲ Q3 FY2025 | Aug 8, 2025 | $0.46 | $1.12 | +146.2% | $0.30B | $0.27B | +11.2% |
| ▲ Q2 FY2025 | May 9, 2025 | $0.66 | $0.70 | +6.1% | $0.26B | $0.28B | -7.1% |
| ▲ Q1 FY2025 | Feb 6, 2025 | $0.45 | $0.65 | +44.4% | $0.26B | $0.26B | -0.9% |
| ▲ Q4 FY2024 | Nov 26, 2024 | $0.36 | $0.45 | +25.0% | $0.29B | $0.28B | +3.3% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.26
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Miss
EPS Actual
$0.27
EPS Est.
$0.42
EPS Surpr.
-35.7%
Revenue
$0.22B
Q1 FY2026
Feb 5, 2026Beat
EPS Actual
$0.71
EPS Est.
$0.67
EPS Surpr.
+6.0%
Revenue
$0.26B
Q4 FY2025
Nov 25, 2025Miss
EPS Actual
$0.50
EPS Est.
$0.70
EPS Surpr.
-28.6%
Revenue
$0.26B
Q3 FY2025
Aug 8, 2025Beat
EPS Actual
$1.12
EPS Est.
$0.46
EPS Surpr.
+146.2%
Revenue
$0.30B
Q2 FY2025
May 9, 2025Beat
EPS Actual
$0.70
EPS Est.
$0.66
EPS Surpr.
+6.1%
Revenue
$0.26B
Q1 FY2025
Feb 6, 2025Beat
EPS Actual
$0.65
EPS Est.
$0.45
EPS Surpr.
+44.4%
Revenue
$0.26B
Q4 FY2024
Nov 26, 2024Beat
EPS Actual
$0.45
EPS Est.
$0.36
EPS Surpr.
+25.0%
Revenue
$0.29B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2028 | $0.59 | $0.60 | $0.61 | 2 |
| Q2 FY2028 | $0.51 | $0.52 | $0.53 | 2 |
| Q1 FY2028 | $0.44 | $0.45 | $0.45 | 3 |
| Q4 FY2027 | $0.44 | $0.45 | $0.46 | 2 |
| Q3 FY2027 | $0.48 | $0.49 | $0.49 | 1 |
| Q2 FY2027 | $0.45 | $0.45 | $0.46 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2028 | $0.3B | $0.3B | $0.3B | 1 |
| Q2 FY2028 | $0.3B | $0.3B | $0.3B | 1 |
| Q1 FY2028 | $0.3B | $0.3B | $0.3B | 2 |
| Q4 FY2027 | $0.3B | $0.3B | $0.3B | 3 |
| Q3 FY2027 | $0.3B | $0.3B | $0.3B | 2 |
| Q2 FY2027 | $0.3B | $0.3B | $0.3B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 5, 2026 | -35.7% | $9.25 | $3.90 | -57.84% |
| ▲ Q1 FY2026 | Feb 5, 2026 | +6.0% | $11.35 | $10.47 | -7.75% |
| ▼ Q4 FY2025 | Nov 25, 2025 | -28.6% | $14.64 | $13.58 | -7.24% |
| ▲ Q3 FY2025 | Aug 8, 2025 | +146.2% | $10.36 | $12.28 | +18.53% |
| ▲ Q2 FY2025 | May 9, 2025 | +6.1% | $13.30 | $11.97 | -10.00% |
| ▲ Q1 FY2025 | Feb 6, 2025 | +44.4% | $18.20 | $17.73 | -2.58% |
| ▲ Q4 FY2024 | Nov 26, 2024 | +25.0% | $14.41 | $18.70 | +29.77% |
| ▲ Q3 FY2024 | Aug 9, 2024 | +54.2% | $14.34 | $15.39 | +7.32% |
Q2 FY2026-57.84%
Report Date
May 5, 2026
EPS Beat/Miss
-35.7%
Price Before
$9.25
Price After
$3.90
Q1 FY2026-7.75%
Report Date
Feb 5, 2026
EPS Beat/Miss
+6.0%
Price Before
$11.35
Price After
$10.47
Q4 FY2025-7.24%
Report Date
Nov 25, 2025
EPS Beat/Miss
-28.6%
Price Before
$14.64
Price After
$13.58
Q3 FY2025+18.53%
Report Date
Aug 8, 2025
EPS Beat/Miss
+146.2%
Price Before
$10.36
Price After
$12.28
Q2 FY2025-10.00%
Report Date
May 9, 2025
EPS Beat/Miss
+6.1%
Price Before
$13.30
Price After
$11.97
Q1 FY2025-2.58%
Report Date
Feb 6, 2025
EPS Beat/Miss
+44.4%
Price Before
$18.20
Price After
$17.73
Q4 FY2024+29.77%
Report Date
Nov 26, 2024
EPS Beat/Miss
+25.0%
Price Before
$14.41
Price After
$18.70
Q3 FY2024+7.32%
Report Date
Aug 9, 2024
EPS Beat/Miss
+54.2%
Price Before
$14.34
Price After
$15.39
Avg Beat Reaction+5.88%
Avg Miss Reaction-32.54%
Beat Rate6 / 8 quarters
Largest Move-57.84% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: EMBC ends December
Embecta Corp. (EMBC) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $0.27 — missing the analyst consensus of $0.42 by -35.7%. The next EMBC earnings date is expected around September 1, 2026.
Each quarter, investors track EMBC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EMBC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EMBC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
EMBC earnings · 5 questionsEmbecta Corp.'s next earnings report is expected around September 1, 2026. EMBC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EMBC historically reports after market close (AMC).
EMBC earnings datewhen is EMBC earningsEMBC next earnings datewhen does EMBC report earningsEMBC earnings calendar
▸ Source: FMP · Embecta Corp. SEC filings · US GAAP · Embecta Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026